Post-Remission Therapy for Acute Myelogenous Leukemia

[1]  J. Fahey,et al.  Bone-marrow transplantation in acute leukaemia. , 1977, Lancet.

[2]  R. Storb,et al.  Marrow transplantation from related donors other than HLA-identical siblings. , 1985, The New England journal of medicine.

[3]  D. S. Gordon,et al.  A randomized comparison of postremission therapy in acute myelogenous leukemia: a Southeastern Cancer Study Group trial. , 1984, Blood.

[4]  D. Hedley,et al.  MISMATCHED FAMILY DONORS FOR BONE-MARROW TRANSPLANTATION AS TREATMENT FOR ACUTE LEUKAEMIA , 1983, The Lancet.

[5]  D. Findley,et al.  Bone Marrow Ablation Followed by Allogeneic Marrow Grafting During First Complete Remission of Acute Nonlymphocytic Leukemia , 1983 .

[6]  E. Gehan,et al.  Improved prospects for long-term survival in adults with acute myelogenous leukemia. , 1982, JAMA.

[7]  A. Rimm,et al.  BONE-MARROW TRANSPLANTATION FOR ACUTE LEUKAEMIA IN FIRST REMISSION , 1982, The Lancet.

[8]  J. Armitage,et al.  Results of aggressive chemotherapy for acute nonlymphoblastic leukemia in adults. , 1982, Cancer treatment reports.

[9]  R. Mertelsmann,et al.  Acute nonlymphoblastic leukemia. Prognostic factors in adults with long‐term follow‐up , 1982, Cancer.

[10]  N. Nissen,et al.  Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB study. , 1982, Blood.

[11]  R. Bast,et al.  AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN CALLA-POSITIVE ACUTE LYMPHOBLASTIC LEUKAEMIA AFTER IN-VITRO TREATMENT WITH J5 MONOCLONAL ANTIBODY AND COMPLEMENT , 1982, The Lancet.

[12]  G. Santos,et al.  Bone marrow transplantation in acute leukemia. , 1982, Seminars in hematology.

[13]  T. Lister,et al.  Short-term treatment for acute myelogenous leukaemia. , 1982, British medical journal.

[14]  J. Lefante,et al.  Treatment of acute myelogenous leukemia: Influence of three induction regimens and maintenance with chemotherapy or BCG immunotherapy , 1982, Cancer.

[15]  J. Ritz,et al.  Monoclonal antibody-ricin A chain conjugate selectively cytotoxic for cells bearing the common acute lymphoblastic leukemia antigen. , 1982, Cancer research.

[16]  J H Goldie,et al.  Rationale for the use of alternating non-cross-resistant chemotherapy. , 1982, Cancer treatment reports.

[17]  A. Cooper.  Hodgkin's disease. , 1982, Lancet.

[18]  E. Thomas,et al.  Marrow transplantation for patients with acute nonlymphoblastic leukemia who achieve a first remission. , 1982, Cancer treatment reports.

[19]  C. Bloomfield,et al.  Treatment of acute myelocytic leukemia: a study by cancer and leukemia group B. , 1981, Blood.

[20]  V. Farewell,et al.  High‐dose combination chemotherapy for acute nonlymphoblastic leukemia in adults , 1981, Cancer.

[21]  R. Good,et al.  TRANSPLANTATION FOR ACUTE LEUKAEMIA WITH HLA-A AND B NONIDENTICAL PARENTAL MARROW CELLS FRACTIONATED WITH SOYBEAN AGGLUTININ AND SHEEP RED BLOOD CELLS , 1981, The Lancet.

[22]  R. Miller,et al.  In vivo effects of murine hybridoma monoclonal antibody in a patient with T-cell leukemia. , 1981, Blood.

[23]  E. Gehan,et al.  A four‐year experience with anthracycline, cytosine arabinoside, vincristine and prednisone combination chemotherapy in 325 adults with acute leukemia , 1981, Cancer.

[24]  K. Foon,et al.  Intensive chemotherapy for acute myelogenous leukemia. , 1981, Annals of internal medicine.

[25]  C. Bloomfield,et al.  Long-term disease-free survival in acute nonlymphocytic leukemia. , 1981, Blood.

[26]  M. Keating,et al.  Combination of high-dose cyclophosphamide, BCNU, and VP-16-213 followed by autologous marrow rescue in the treatment of relapsed leukemia. , 1981, Cancer treatment reports.

[27]  C. Gisselbrecht,et al.  Anthracyclines in the treatment of acute nonlymphocytic leukemias. , 1981, Cancer treatment reports.

[28]  F. Mandelli,et al.  Randomized clinical trial of immunotherapy and androgenotherapy for remission maintenance in acute non-lymphocytic leukemia. , 1981, Leukemia research.

[29]  T. Lister,et al.  Chemotherapy and immunotherapy for acute myelogenous leukemia , 1980, Cancer.

[30]  D. Rosenthal,et al.  Treatment of acute myelogenous leukemia in children and adults. , 1980, The New England journal of medicine.

[31]  C. Bloomfield,et al.  Intensive five‐drug combination chemotherapy for adult acute non‐lymphocytic leukemia , 1980, Cancer.

[32]  D. Hedley,et al.  THE PLACE OF BONE-MARROW TRANSPLANTATION IN ACUTE MYELOGENOUS LEUKÆMIA , 1980, The Lancet.

[33]  E. Scott,et al.  Bone-marrow ablation and allogeneic marrow transplantation in acute leukemia. , 1980, The New England journal of medicine.

[34]  Mark L. Greenberg,et al.  Central nervous system involvement at presentation in acute granulocytic leukemia. A prospective cytocentrifuge study. , 1980, The American journal of medicine.

[35]  T. L. Smith,et al.  Factors related to length of complete remission in adult acute leukemia , 1980, Cancer.

[36]  J. Karp,et al.  Long chemotherapy‐free remissions after single‐cycle timed‐sequential chemotherapy for acute myelocytic leukemia , 1980, Cancer.

[37]  J. Tooth,et al.  Immunotherapy alone vs no maintenance treatment in acute myelogenous leukaemia. , 1980, British Journal of Cancer.

[38]  C. Russo,et al.  Chemoimmunotherapy with corynebacterium parvum in acute myelocytic leukemia , 1980, Cancer.

[39]  M. S. Tobin,et al.  Cyclophosphamide, cytosine arabinoside and methotrexate versus cytosine arabinoside and thioguanine for acute non‐lymphocytic leukemia in adults , 1980, Cancer.

[40]  P. Neiman,et al.  Marrow transplantation for acute nonlymphoblastic leukemia in first remission. , 1979, The New England journal of medicine.

[41]  J. Petit,et al.  High dose combination chemotherapy (TACC) with and without autologous bone marrow transplantation for the treatment of acute leukaemia and other malignant diseases: kinetics of recovery of haemopoiesis. A preliminary study of 12 cases. , 1979, European journal of cancer.

[42]  R. Bukowski,et al.  Prognostic factors affecting remission, remission duration, and survival in adult acute nonlymphocytic leukemia , 1979, Cancer.

[43]  Goldie Jh,et al.  A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. , 1979 .

[44]  E. Henderson,et al.  Treatment of acute nonlymphocytic leukemia: use of anthracycline-cytosine arabinoside induction therapy and comparison of two maintenance regimens. , 1979, Blood.

[45]  F. Mandelli,et al.  Daunorubicin, cytosine arabinoside and 6-thioguanine (DAT) combination chemotherapy for the treatment of acute non-lymphocytic leukemia. , 1979, Leukemia research.

[46]  B. Coiffier,et al.  BCG therapy in acute non lymphoid leukaemias. , 2009, Scandinavian journal of haematology.

[47]  G. Dahl,et al.  Preventive central nervous system irradiation in children with acute nonlymphocytic leukemia , 1978, Cancer.

[48]  A. Zander,et al.  AUTOLOGOUS BONE MARROW TRANSPLANTATION IN PATIENTS WITH ADULT ACUTE LEUKEMIA IN RELAPSE , 1978, Transplantation.

[49]  K. Yamada,et al.  A clinical trial of cell-wall skeleton of BCG in chemoimmunotherapy of acute leukemia. , 1978, Gan.

[50]  W. Terry,et al.  Immunotherapy of cancer : present status of trials in man , 1978 .

[51]  F. Hayhoe,et al.  Treatment of acute myeloid leukaemia with a triple cytotoxic regime: DAT. , 1977, British Journal of Cancer.

[52]  Cassileth Pa,et al.  Chemotherapy for adult acute nonlymphocytic leukemia with daunorubicin and cytosine arabinoside. , 1977 .

[53]  J. Blom,et al.  Adult acute leukemia. Frequency of central nervous system involvement in long term survivors , 1977 .

[54]  P. Neiman,et al.  One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. , 1977, Blood.

[55]  T. Lister,et al.  Immunotherapy for acute myelogenous leukaemia: a controlled clinical study 2 1/2 years after entry of the last patient. , 1977, British Journal of Cancer.

[56]  M. O’connell,et al.  Randomized clinical comparison of daunorubicin (NSC-82151) alone with a combination of daunorubicin, cytosine arabinoside (NSC-63878), 6-thioguanine (NSC-752), and pyrimethamine (NSC-3061) for the treatment of acute nonlymphocytic leukemia. , 1976, Cancer treatment reports.

[57]  C. Spurr,et al.  Comparative study of cytosine arabinoside therapy alone and combined with thioguanine, mercaptopurine, or daunorubicin in acute myelocytic leukemia , 1975, Cancer.

[58]  A. Bold.  EFFECTS OF NEW N.H.S. CONTRACTS ON RECRUITMENT , 1975, The Lancet.

[59]  W. Vogler,et al.  Prolonging remission in myeloblastic leukemia by tice-strain bacillus Calmette-Guérin. , 1974, Lancet.

[60]  E. Freireich,et al.  The incidence of central nervous system leukemia in adults with acute leukemia , 1974, Cancer.

[61]  N. Breslow.  Covariance analysis of censored survival data. , 1974, Biometrics.

[62]  E. Gehan,et al.  Chemotherapy of acute leukemia. Comparison of cytarabine alone and in combination with vincristine, prednisone, and cyclophosphamide. , 1974, Archives of internal medicine.

[63]  E. Gehan,et al.  Cytarabine for acute leukemia in adults. Effect of schedule on therapeutic response. , 1974, Archives of internal medicine.

[64]  F. S. Muriel,et al.  Factors that influence the appearance of central nervous system leukemia. , 1973, Blood.

[65]  C. Coltman,et al.  POMP combination chemotherapy of adult acute leukemia , 1973, Cancer.

[66]  M. Boiron,et al.  Acute promyelocytic leukemia: results of treatment by daunorubicin. , 1973, Blood.

[67]  P. Wiernik,et al.  A randomized clinical trial of daunorubicin and a combination of prednisone, vincristine, 6-mercaptopurine, and methotrexate in adult acute nonlymphocytic leukemia. , 1972, Cancer research.

[68]  B. Hoogstraten,et al.  Intermittent therapy with 6-mercaptopurine (NSC-755) and methotrexate (NSC-740) given intravenously to adults with acute leukemia. , 1972, Cancer chemotherapy reports.

[69]  D. Cox.  Regression Models and Life-Tables , 1972 .

[70]  David R. Cox,et al.  Regression models and life tables (with discussion , 1972 .

[71]  B. Leventhal,et al.  Cytosine arabinoside in acute granulocytic leukemia , 1971, Clinical pharmacology and therapeutics.

[72]  J. Whittaker,et al.  Cytosine arabinoside in the treatment of acute myeloblastic leukaemia. , 1971, Lancet.

[73]  W. Vogler.  Clinical trials of 1‐β‐D‐arabinofuranosyl cytosine and 1,3‐bis‐(2‐chloroethyl)‐1‐nitrosourea combination in metastatic cancer and acute leukemia , 1971 .

[74]  D. Cox,et al.  The analysis of binary data , 1971 .

[75]  G. Mathé,et al.  Active immunotherapy for acute lymphoblastic leukaemia. , 1969, Lancet.

[76]  M. Boiron,et al.  Daunorubicin in the treatment of acute myelocytic leukaemia. , 1969, Lancet.

[77]  E. Freireich,et al.  Cytosine arabinoside (NSC-63878) therapy for acute leukemia in adults. , 1969, Cancer chemotherapy reports.

[78]  C. Spurr,et al.  Arabinosyl cytosine: a useful agent in the treatment of acute leukemia in adults. , 1968, Blood.

[79]  E. Henderson.  Treatment of acute leukemia. , 1968, Annals of internal medicine.

[80]  J. Harris,et al.  Therapy for acute granulocytic leukemia. , 1967, Cancer research.

[81]  R. Rundles,et al.  Comparison of methotrexate with 6‐mercaptopurine–prednisone in treatment of acute leukemia in adults , 1967, Cancer.

[82]  T. Hall,et al.  Combination therapy of adult acute myelogenous leukemia: experience with the simultaneous use of vincristine, amethopterin, 6-mercaptopurine and prednisone. , 1965, The New England journal of medicine.

[83]  E. Gehan.  A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES. , 1965, Biometrika.

[84]  K. Hirschhorn,et al.  ROLE OF LYSOSOMES IN LYMPHOCYTE RESPONSE. , 1965, Lancet.

[85]  Williams Jt,et al.  ROYAL COLLEGE OF PHYSICIANS. THE NEW BUILDING. , 1964, Lancet.

[86]  E. Frei.  Chemotherapy of acute leukemia , 1964, CA: a cancer journal for clinicians.

[87]  Zadik Fr.  SOCIAL ASPECTS OF OBSTETRICS AND GYNAECOLOGY. , 1964 .

[88]  G. Cartwright,et al.  THE ACUTE LEUKEMIAS: Analysis of 322 Cases and Review of the Literature , 1962, Medicine.

[89]  E. Freireich,et al.  A comparative study of two regimens of combination chemotherapy in acute leukemia. , 1958, Blood.

[90]  C. Rimington,et al.  Folic acid in megaloblastic anemia after total gastrectomy; report of a case. , 1947, Lancet.